Upregulation of human DNA binding protein A (dbpA) in gastric cancer cells

Acta Pharmacologica Sinica

Volumn 30, Issue 10, 2009, Pages 1436-1442

  Wang, Guo Rong ^a,b   Zheng, Yan ^c   Che, Xiang Ming ^a   Wang, Xin Yang ^a   Zhao, Jia Hui ^a   Wu, Kai Jie ^a   Zeng, Jin ^a   Pan, Chen En ^a   He, Da Lin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

^c THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

CSDA protein, human; Fluorouracil; Small interfering RNA; Stomach neoplasms

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; APC PROTEIN; BETA CATENIN; CYCLIN D1; DNA BINDING PROTEIN; DNA BINDING PROTEIN A; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER TISSUE; CELL INVASION; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; WESTERN BLOTTING;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANTINEOPLASTIC AGENTS; BETA CATENIN; CADHERINS; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; COLORING AGENTS; CULTURE MEDIA, SERUM-FREE; CYCLIN D1; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUOROURACIL; HEAT-SHOCK PROTEINS; HUMANS; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION; UP-REGULATION;

EID: 70350637530     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.137     Document Type: Article

References (21)

1. Leung W, Wu M, Kakugawa Y, Kim J, Yeoh K, Goh K, et al. Screening for gastric cancer in Asia: current evidence and practice. The Lancet Oncology 2008; 9: 279-287
2. Sakura H, Maekawa T, Imamoto F, Yasuda K, Ishii S. Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology. Gene 1988; 73: 499-507.
3. Kudo S, Mattei MG, Fukuda M. Characterization of the gene for dbpA, a family member of the nucleic-acid-binding proteins containing a cold-shock domain. Eur J Biochem 1995; 231: 72-82.
4. Balda MS, Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 2000; 19: 2024-2033
5. Wolffe AP. Structural and functional properties of the evolutionarily ancient Y-box family of nucleic acid binding proteins. Bioessays 1994; 16: 245-251
6. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 2003; 25: 691-698
7. Uramoto H, Izumi H, Ise T, Tada M, Uchiumi T, Kuwano M, et al. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. J Biol Chem 2002; 277: 31694-31702
8. Sourisseau T, Georgiadis A, Tsapara A, Ali RR, Pestell R, Matter K, et al. Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/ DbpA. Mol Cell Biol 2006; 26: 2387-2398
9. Tobita H, Kajino K, Sayaka K, Yasen M, Imamura O, Kinoshta Y, et al. Gene expression profile of DNA binding protein A transgenic mice. Int J Oncol 2006; 29: 673-679
10. Arakawa Y, Kajino K, Kano S, Tobita H, Hayashi J, Yasen M, et al. Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis. Biochem Biophys Res Commun 2004; 322: 297-302.
11. Yasen M, Kajino K, Kano S, Tobita H, Yamamoto J, Uchiumi T, et al. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma. Clin Cancer Res 2005; 11: 7354-7361
12. Zhang LL, He DL, Li X, Li L, Zhu GD, Zhang D, et al. Overexpression of coxsackie and adenovirus receptor inhibit growth of human bladder cancer cell in vitro and in vivo. Acta Pharmacol Sin 2007; 28: 895-900.
13. Koike K, Uchiumi T, Ohga T, Toh S, Wada M, Kohno K, et al. Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett 1997; 417: 390-394
14. Ebert MP, Yu J, Hoffmann J, Rocco A, Röcken C, Kahmann S, et al. Loss of beta-catenin expression in metastatic gastric cancer. J Clin Oncol 2003; 21: 1708-1714 (Pubitemid 46638581)
15. Jawhari AU, Noda M, Farthing MJ, Pignatelli M. Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines. Br J Cancer 1999; 80: 322-330
16. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-1455
17. Beavon IR. The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer 2000; 36: 1607-1620
18. Ilyas M, Tomlinson IP. The interactions of APC, E-cadherin and betacatenin in tumour development and progression. J Pathol 1997; 182: 128-137
19. Shtutman M, Zhurinsky J, Simcha I, Albanese C, Amico MD, Pestell R. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-5527
20. Kuwano M, Oda Y, Izumi H, Yang SJ, Uchiumi T, Iwamoto Y. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol Cancer Ther 2004; 3: 1485-1492
21. Guay D, Garand C, Reddy S, Schmutte C, Lebel M. The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells. Cancer Sci 2008; 99: 762-769